title: Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma.
authors.forename: Amer
authors.initials: A
authors.lastname: Zeidan
authors.forename: Bishoy
authors.initials: B
authors.lastname: Faltas
authors.forename: William
authors.initials: W
authors.lastname: Fricke
authors.forename: Steven
authors.initials: S
authors.lastname: Gore
authors.forename: Rhett
authors.initials: R
authors.lastname: Ketterling
authors.forename: Ronald
authors.initials: R
authors.lastname: Sham
mesh_terms: D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000235:genetics; D018450:Disease Progression; D005260:Female; D016298:Hematopoietic Cell Growth Factors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D059785:Karyotype; D017254:Leukemic Infiltration; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000209:etiology*; D012074:Remission Induction
chemical_list: D016298:Hematopoietic Cell Growth Factors